Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-05

Clinical Trial Update: Ursodiol in Huntington's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ursodiol for Huntington's disease; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Huntington Disease | Phase 1 | Status: UNKNOWN